Methylation of SPARCL1 Is Associated with Oncologic Outcome of Advanced Upper Urinary Tract Urothelial Carcinoma
Abstract
Share and Cite
Luo, H.-L.; Chiang, P.-H.; Huang, C.-C.; Su, Y.-L.; Sung, M.-T.; Tsai, E.-M.; Lin, C.-S.; Chiang, P.-H. Methylation of SPARCL1 Is Associated with Oncologic Outcome of Advanced Upper Urinary Tract Urothelial Carcinoma. Int. J. Mol. Sci. 2019, 20, 1653. https://doi.org/10.3390/ijms20071653
Luo H-L, Chiang P-H, Huang C-C, Su Y-L, Sung M-T, Tsai E-M, Lin C-S, Chiang P-H. Methylation of SPARCL1 Is Associated with Oncologic Outcome of Advanced Upper Urinary Tract Urothelial Carcinoma. International Journal of Molecular Sciences. 2019; 20(7):1653. https://doi.org/10.3390/ijms20071653
Chicago/Turabian StyleLuo, Hao-Lun, Po-Huang Chiang, Chun-Chieh Huang, Yu-Li Su, Min-Tse Sung, Eing-Mei Tsai, Chang-Shen Lin, and Po-Hui Chiang. 2019. "Methylation of SPARCL1 Is Associated with Oncologic Outcome of Advanced Upper Urinary Tract Urothelial Carcinoma" International Journal of Molecular Sciences 20, no. 7: 1653. https://doi.org/10.3390/ijms20071653
APA StyleLuo, H.-L., Chiang, P.-H., Huang, C.-C., Su, Y.-L., Sung, M.-T., Tsai, E.-M., Lin, C.-S., & Chiang, P.-H. (2019). Methylation of SPARCL1 Is Associated with Oncologic Outcome of Advanced Upper Urinary Tract Urothelial Carcinoma. International Journal of Molecular Sciences, 20(7), 1653. https://doi.org/10.3390/ijms20071653

